RAC agrees on 33 draft opinions for authorisation and adopts 8 opinions on harmonised classification and labelling
Committee for Risk Assessment's (RAC) draft opinions concern several uses of hexavalent chromium compounds as well as arsenic acid, 1,2-dichloroethane (EDC) and bis(2-methoxyethyl) ether (Diglyme).
Helsinki, 10 June 2016 - RAC agreed on 30 draft opinions on the uses of hexavalent chromium compounds, mainly in various types of functional chrome plating, use in electronics industry, and corrosion inhibition. Three other draft opinions were on the use of arsenic acid in electronics industry, the specific solvent use applications of 1,2-dichloroethane (EDC) and bis(2-methoxyethyl) ether (Diglyme).
The Committee also discussed the key issues identified in the 14 applications for authorisation of chromates, eight applications on the uses of EDC, six applications on the uses of Diglyme and one application on the uses of oligomeric reaction products of formaldehyde with aniline (technical MDA). These applications were received in the February 2016 submission window.
The Committee's draft opinions on applications for authorisation are sent to applicants for commenting. If no comments are received the opinion will become final. If comments are received the Committee will consider the comments and then adopt its final opinion. ECHA will publish RAC's final opinions on the Agency's website.
The Committee also adopted eight opinions on harmonised classification and labelling.
More details of these opinions are available in the annex.
The Committee is responsible for preparing the opinion of the Agency on applications for authorisation, proposals for restrictions and proposals for harmonised classification and labelling. RAC also prepares opinions on specific questions relating to risks of chemicals to human health or the environment and on any other aspects concerning the safety of substances at the Executive Director's request. The final decision for proposals for harmonised classification and labelling, for proposals for restrictions as well as on applications for authorisation will be taken by the European Commission through a committee procedure.
Further information about RAC is available on the ECHA website at the link below: